SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
The China Fund, Inc. (CHN) trades at a trailing P/E of 6.5. Trailing earnings yield is 15.29%. PEG 0.04 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (6.5); PEG ≤ 1.0 — Peter Lynch undervalued (0.04); earnings yield beats bond yields (15.29%).
- PEG Ratio 0.04 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 15.29% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 66/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CHN
Valuation Multiples
P/E (TTM)6.5
Forward P/EN/A
PEG Ratio0.04
Forward PEGN/A
P/B Ratio0.00
P/S Ratio6.36
EV/EBITDA0.0
Per Share Data
EPS (TTM)$2.78
Book Value / Share$0.00
Revenue / Share$2.86
FCF / Share$0.00
Yields & Fair Value
Earnings Yield15.29%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-0.54 |
$8.62M |
$-8.46M |
-98.1% |
| 2016 |
$15,412,800.00 |
$-23.44M |
$5.79M |
- |
| 2017 |
$5.00 |
$81.15M |
$78.64M |
96.9% |
| 2018 |
$-3.78 |
$-54.89M |
$-59.44M |
- |
| 2019 |
$5.36 |
$59M |
$57.15M |
96.9% |
| 2020 |
$10.10 |
$106.61M |
$105.57M |
99% |
| 2021 |
$1.09 |
$12.36M |
$11.33M |
91.7% |
| 2022 |
$-11.55 |
$-117.47M |
$-118.47M |
- |
| 2023 |
$1.01 |
$11.22M |
$10.1M |
90.1% |
| 2024 |
$2.78 |
$28.21M |
$27.23M |
96.5% |
